What Analysts Are Saying About UnitedHealth Group Stock
Portfolio Pulse from Benzinga Insights
UnitedHealth Group (NYSE:UNH) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target for UNH is $583.22, slightly up from the previous $583.00. Analysts from firms like RBC Capital, Stephens & Co., Cantor Fitzgerald, Oppenheimer, Piper Sandler, and HSBC have maintained or adjusted their ratings and price targets, reflecting their views on the company's market position and financial health. UnitedHealth Group, a leading private health insurer, has shown strong financial performance with notable revenue growth, net margin, ROE, and ROA, despite a higher debt-to-equity ratio compared to industry averages.
February 29, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UnitedHealth Group has received predominantly somewhat bullish ratings from analysts, with a slight increase in the average 12-month price target to $583.22. The company's financial health appears robust, marked by significant revenue growth, high net margin, ROE, and ROA, despite a higher debt-to-equity ratio.
The somewhat bullish sentiment from analysts, combined with the slight increase in the average price target, suggests a positive outlook for UNH's stock price in the short term. The company's strong financial indicators, such as revenue growth, net margin, ROE, and ROA, support this optimism. However, the higher debt-to-equity ratio is a point of caution that might temper overly bullish expectations.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100